Efficacy of nivolumab as second line treatment for recurrent or metastatic Head and Neck Squamous Cell Carcinoma: A national DAHANCA cohort study

Sebastian Søby*, Anita Gothelf, Niels Gyldenkerne, Jens Bentzen, Kinga Nowicka-Matus, Trine Tramm, Jesper Grau Eriksen

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy of nivolumab as second line treatment for recurrent or metastatic Head and Neck Squamous Cell Carcinoma: A national DAHANCA cohort study'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology